Primary multiple non-hereditary malignant neoplasms
Yu. M. Paderov,
Kh. L. Mavidi,
L. D. Zhuikova,
L. V. Pikalova,
M. V. Zavyalova,
D. S. Pismenny,
A. V. Zavyalov,
G. A. Kononova,
O. A. Ananina https://doi.org/10.25789/YMJ.2024.88.24
Abstract
Carcinogenesis is based on a multistage process of changes, malignant transformation and progression, which includes DNA damage and dysfunction of the immune system. Damage to certain parts of genes involved in mitosis, cell death or DNA repair is reflected in an increase in the mutation load. After accumulation of a sufficient number of mutations, control over cell function is disrupted, which leads to the development of cancer. In recent years, an increase in the frequency of multiple primary neoplasms has been noted. The review presents the main risk factors that to one degree or another affect the development of polyneoplasia.
About the Authors
Yu. M. Paderov
ФГБОУ ВО СибГМУ Минздрава России
Russian Federation
Russian Federation
Kh. L. Mavidi
ФГБОУ ВО СибГМУ Минздрава России
Russian Federation
Russian Federation
L. D. Zhuikova
Томский НИМЦ
Russian Federation
Russian Federation
L. V. Pikalova
НИИ онкологии Томского НИМЦ
Russian Federation
Russian Federation
M. V. Zavyalova
НИИ онкологии Томского НИМЦ; ФГБОУ ВО СибГМУ Минздрава России
Russian Federation
Russian Federation
D. S. Pismenny
НИИ онкологии Томского НИМЦ; ФГБОУ ВО СибГМУ Минздрава России
Russian Federation
Russian Federation
A. V. Zavyalov
ФГБОУ ВО «Сибирский государственный медицинский университет» МЗ РФ
Russian Federation
Russian Federation
G. A. Kononova
НИИ онкологии Томского НИМЦ
Russian Federation
Russian Federation
O. A. Ananina
НИИ онкологии Томского НИМЦ
Russian Federation
Russian Federation
References
1. Malignant neoplasms in Russia in 2023 (incidence and mortality). Ed. by Kaprin A.D. et al. Moscow: P.A. Herzen Moscow Oncology Research Institute - branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, 2024.
2. Musaelyan A.A., Nazarov V.D., Budnikova A.S. Clinical and morphological portrait of tumors with microsatellite instability. Advances in Molecular Oncology // 2021. Vol. 8, No. 2. Р. 52-59. https://doi.org/10.17650/2313-805X-2021-8-2-52-59
3. Selye G. Stress without Distress / Ed. by E. M. Kreps. Moscow: Progress, 1982.
4. Styazhkina S.N., Idiatullin R.M., Gevorkyan A.G., Moskvina JU.V. Primary-multiple malignant tumors // Capital of science. 2020. No. 1 (18). Р. 15-21.
5. Sultanbaev A.V., Menshikov K.V., Musin Sh.I. Predictors of Multiple Primary Malignancies: Literature Review // Creative surgery and oncology. 2023. Vol. 13. No. 3. Р. 221-228. https://doi.org/10.24060/2076-3093-2023-3-221-228.
6. Torba A.V., Ryabtseva O.D., Pertsova, Yu.G. Primary - multiple tumors // Neoplasm. 2021. Vol. 13, No. 1 (32). Р. 34-47. https://doi.org/10.26435/neoplasm.v13i1.363
7. Khlanta D.A., Gens G.P. Management of patients with multiple primary сancer in the practice of a modern oncologist. Case report and literature review // Siberian Journal of Oncology. 2022. Vol. 21. No. 4. Р. 147–155. https://doi.org/10.21294/1814-4861-2022-21-4-147-155.
8. Chissov V.I. Oncology: National Guidelines. Short Edition. Ed. Chissova V.I., Davydova M.I. M.: GEOTAR-Media. 2017; 576 p. - ISBN 978-5-9704-3982-1.
9. Shunko E.L., Vazhenin A.V., Shanazarov N.A. Empirical models for predicting the second metachronous tumor after chemoradiotherapy of the first in the clinical examination of cancer patients // Radiation and Risk. 2022. Vol. 31, No. 1. Р. 74–82. https://doi.org/10.21870/0131-3878-2022-31-1-74-82
10. Alsulaimani A.I., Alkhaldi L.M., AlTawairqi S.A. [et al.]. A Single-Center Study of Patients With Synchronous Primary Malignancy: A Case Series. Cureus. 2022. Vol. 14. No. 12. Р. e32839. https://doi.org/10.7759/cureus.32839
11. Huang Y, Zhu M, Ji M [et al.]. Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank. Am J Respir Crit Care Med. 2021. Vol. 204. No. 7. Р. 817-825. https://doi.org/10.1164/rccm.202011-4063OC
12. Zhou X., Yu L., Wang L. [et al.] Alcohol consumption, blood DNA methylation and breast cancer: a Mendelian randomisation study. Eur J Epidemiol. 2022. Vol. 37. No. 7. Р. 701-712. https://doi.org/10.1007/s10654-022-00886-1
13. Zhou X., Wang L., Xiao J. [et al.]. Alcohol consumption, DNA methylation and colorectal cancer risk: Results from pooled cohort studies and Mendelian randomization analysis. Int J Cancer. 2022. Vol. 151, No. 1. Р.83-94. https://doi.org/10.1002/ijc.33945
14. Weng M.W., Lee H.W., Park S.H. [et al.]. Aldehydes are the predominant forces inducing DNA damage and inhibiting DNA repair in tobacco smoke carcinogenesis. Proc Natl Acad Sci U S A. 2018. Vol. 115, No. 27. Р. E6152-E6161. https://doi.org/10.1073/pnas.1804869115
15. Nordenskjöld A., Fohlin H., Rosell J. [et al.]. Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy. Breast. 2023. Vol. 71. Р. 63- 68. https://doi.org/10.1016/j.breast.2023.07.010
16. Kusakabe M., Taguchi A., Sone K. [et al.]. Carcinogenesis and management of human papillomavirus-associated cervical cancer. Int J Clin Oncol. 2023. Vol. 28, No. 8. Р. 965-974. https://doi.org/10.1007/s10147-023-02337-7
17. Chimenos-Küstner E., Marques-Soares M.S., Schemel-Suárez M. Consideraciones sobre etiopatogenia y prevención del cáncer orofaríngeo [Aetiopathology and prevention of oropharyngeal cancer] // Semergen. 2019. Vol. 45. No. 7. Р. 497-503. https://doi.org/10.1016/j.semerg.2019.03.004
18. Wang Y., Jiao F., Yao J. [et al.]. Clinical Features of Multiple Primary Malignant Tumors: A Retrospective Clinical Analysis of 213 Chinese Patients at Two Centers. Discov Med. 2021. Vol. 32. No. 166. Р. 65-78.
19. Zheng Y., Sun Y., Kuai Y. [et al.]. Gene expression profiling for the diagnosis of multiple primary malignant tumors. Cancer Cell Int. 2021. Vol. 21. No. 1. Р. 47. https://doi.org/10.1186/s12935-021-01748-8.
20. Haley C.T., Mui U.N., Vangipuram R. [et al.]. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Papillomaviruses and Merkel cell polyomavirus. J Am Acad Dermatol. 2019. Vol. 81. No.1. Р. 1-21. https://doi.org/10.1016/j.jaad.2018.09.062
21. Shen J., Zhou H., Liu J. [et al.]. Incidence and risk factors of second primary cancer after the initial primary human papillomavirus related neoplasms. MedComm. 2020. Vol. 1. No. 3. Р. 400-409. https://doi.org/10.1002/mco2.43
22. Van de Ven S.E.M., Falger J.M., Verhoeven R.H.A. [et al.]. Increased risk of second primary tumours in patients with oesophageal squamous cell carcinoma: a nationwide study in a Western population. United European Gastroenterol J. 2021. Vol. 9. No. 4. Р. 497-506. https://doi.org/10.1177/2050640620977129
23. International rules for multiple primary cancers (ICD-0 third edition) // Eur J Cancer Prev. 2005. Vol. 14. No. 4. Р. 307-8. https://doi.org/10.1097/00008469-200508000-00002.
24. Klebe S., Leigh J., Henderson D.W., Nurminen M. Asbestos, Smoking and Lung Cancer: An Update // Int J Environ Res Public Health. 2019. Vol. 17, No. 1. Р. 258. https://doi. org/10.3390/ijerph17010258
25. Kruk J., Aboul-Enein B.H., Bernstein J., Gronostaj M.. Psychological Stress and Cellular Aging in Cancer: A Meta-Analysis // Oxid Med Cell Longev. 2019. Р. 1270397. https://doi.org/10.1155/2019/1270397
26. Mui U.N., Haley C.T., Vangipuram R., Tyring S.K. Human oncoviruses: Mucocutaneous manifestations, pathogenesis, therapeutics, and prevention: Hepatitis viruses, human T-cell leukemia viruses, herpesviruses, and Epstein-Barr virus // J Am Acad Dermatol. 2019. Vol. 81, No.1. Р. 23-41. https://doi.org/10.1016/j.jaad.2018.10.072
27. Multiple primary and Histology Coding Rules Manual (SEER). URL: https://seer.cancer.gov/tools/mphrules/download.html (01.10.2024)
28. Zhang L., Feng L., Cong H. [et al.]. Multiple primary malignant neoplasms: A case report and literature review. Oncol Lett. 2019. Vol. 18, No. 4. Р. 4210-4220. https://doi.org/10.3892/ol.2019.10779
29. Nosé, V. Diagnostic pathology: familial cancer syndromes, second edition. Philadelphia: Elsevier. 2020; 897 p. ISBN 978-0-323-71204-0.
30. Oyouni A.A. Human papillomavirus in cancer: Infection, disease transmission, and progress in vaccines // J Infect Public Health. 2023. Vol. 16, No. 4. Р. 626-631. https://doi.org/10.1016/j.jiph.2023.02.014
31. Phua Z.J., MacInnis R.J., Jayasekara H. Cigarette smoking and risk of second primary cancer: a systematic review and meta-analysis // Cancer Epidemiol. 2022. Vol. 78. Р. 102160. https://doi.org/10.1016/j.canep.2022.102160
32. Santucci C., Carioli G., Bertuccio P. [et al.]. Progress in cancer mortality, incidence, and survival: a global overview. European journal of cancer prevention. 2020. Vol. 29, No. 5. Р. 367-381.
33. Nugent T.S., Low E.Z., Fahy M.R. [et al.]. Prostate radiotherapy and the risk of secondary rectal cancer-a meta-analysis. Int J Colorectal Dis. 2022. Vol. 37, No. 2. Р. 437-447. https://doi.org/10.1007/s00384-021-04075-6
34. Maier A., Wiedemann J., Rapp F. [et al.] Radon Exposure-Therapeutic Effect and Cancer Risk. Int J Mol Sci. 2020. Vol. 22, No.1. Р. 316. https://doi.org/10.3390/ijms22010316
35. Liberale C, Soloperto D, Marchioni A. [et al.] Risk Factors and Oncogenesis. Int J Mol Sci. 2023. Vol. 24, No. 16. Р. 12913. https://doi.org/10.3390/ijms241612913
36. Schuller H.M. The impact of smoking and the influence of other factors on lung cancer // Expert Rev Respir Med. 2019. Vol. 13, No. 8. Р. 761-769. https://doi.org/10.1080/17476348.2019.1645010
37. Starek-Świechowicz B., Budziszewska B., Starek A. Alcohol and breast cancer // Pharmacol Rep. 2023. Vol. 75, No. 1. Р. 69-84. https://doi.org/10.1007/s43440-022-00426-4
38. Afrisham R., Paknejad M., Soliemanifar O. [et al.] The Influence of Psychological Stress on the Initiation and Progression of Diabetes and Cancer. Int J Endocrinol Metab. 2019. Vol. 17, No. 2. Р. e67400. https://doi.org/10.5812/ijem.67400
39. Marchand L., Amos C.I., Hung R.J. [et al.] Tobacco Smoking and Risk of Second Primary Lung Cancer. J Thorac Oncol. 2021. Vol. 16, No.6. Р. 968-979. https://doi.org/10.1016/j.jtho.2021.02.024
40. Hatano Y., Ideta T., Hirata A. [et al.] Virus-Driven Carcinogenesis. Cancers (Basel). 2021. Vol. 13, No. 11. Р. 2625. https://doi.org/10.3390/cancers13112625
41. Yang T., Qiao Y., Xiang S. [et al.] Work stress and the risk of cancer: A meta-analysis of observational studies. Int J Cancer. 2019. Vol. 144, No. 10. Р. 2390-2400. https://doi.org/10.1002/ijc.31955
42. Yang J., Wu F., An H., Gan H. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer // Int J Colorectal Dis. 2023. Vol. 38, No. 1. Р. 88. https://doi.org/10.1007/s00384-023-04366-0
43. Yu X., Chen J., Jiang W., Zhang D. Alcohol, Alcoholic Beverages and Risk of Esophageal Cancer by Histological Type: A Dose-Response Meta-Analysis of Observational Studies // Alcohol. 2020. Vol. 55, No. 5. Р. 457-467. https://doi.org/10.1093/alcalc/agaa047
44. Zareie B., Rasouli M.A., Poorolajal J. Risk of primary lung cancer after breast cancer radiotherapy: a systematic review and meta-analysis // Breast Cancer. 2022. Vol. 29, No. 2. Р. 361-367. https://doi.org/10.1007/s12282-021-01318-w
Review
For citations:
Paderov Yu.M., Mavidi Kh.L., Zhuikova L.D., Pikalova L.V., Zavyalova M.V., Pismenny D.S., Zavyalov A.V., Kononova G.A., Ananina O.A. Primary multiple non-hereditary malignant neoplasms. Yakut Medical Journal. 2024;(4):103-106. (In Russ.) https://doi.org/10.25789/YMJ.2024.88.24
Views:
42
Email this article 